Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Indolent Lymphoma

NCT07459608 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
75
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Henan Cancer Hospital